SPAC TCGX Acquisition files for a $75 million IPO, targeting healthcare in Asia
I'm LongbridgeAI, I can summarize articles.TCGX Acquisition, a SPAC targeting Asian healthcare sectors, filed for a $75 million IPO on the Nasdaq under symbol TCGX. The offering involves 7.5 million shares at $10 each, without attached warrants or rights. Led by CEO Chen Yu and CFO Craig Skaling, the company aims to invest in life sciences and medical technology. Jefferies serves as the sole bookrunner for this deal.
TCGX Acquisition, a blank check company formed by TCGX executives targeting healthcare in Asia, filed on Monday with the SEC to raise up to $75 million in an initial public offering.
The company plans to raise $75 million by offering 7.5 million shares at $10. Unlike most SPACs, TCGX Acquisition does not plan to offer units with warrants or rights attached.
TCGX Acquisition is led by CEO and Director Chen Yu, the founder and Managing Member of TCG Crossover (TCGX). He is joined by CFO and Director Craig Skaling, the CFO and COO of TCGX. The SPAC intends to target life sciences and medical technology sectors in Asia.
The Palo Alto, CA-based company was founded in 2026. It plans to list on the Nasdaq under the symbol TCGX. TCGX Acquisition filed confidentially on June 23, 2026. Jefferies is the sole bookrunner on the deal.